Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank86
5Y CAGR-7.3%
Studio
Year-over-Year Change

Year-over-year book value per share growth

5Y CAGR
-7.3%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025217.12%
2024-224.93%
202352.12%
2022-47.50%
2021-28.01%
2020317.59%
2019-355.64%
20180.00%